Background: Vulvovaginal candidiasis (VVC) affects approximately 75% of women once in lifetime. National AIDS Control Organization has recommended Kit-2/Green (tablet secnidazole 2 gm OD stat and capsule fluconazole 150 mg stat) for syndromic case management (SCM) patients with vaginal discharge since 2007. Patients are frequently revisiting the STI centre recurrent VVC. The purpose study was t...

OBJECTIVE To determine the association between use of vaginal estrogen and risk of a global index event (GIE), defined as time to first occurrence of coronary heart disease (CHD), invasive breast cancer, stroke, pulmonary embolism, hip fracture, colorectal cancer, endometrial cancer, or death from any cause. METHODS For this prospective observational cohort study, we used data from participan...

OBJECTIVE To test the effectiveness and safety of low-dose vaginal misoprostol for induction of labor with a live fetus. METHODS Labor was induced in 666 pregnant women with a live fetus in the cephalic position, who had no medical complications and no history of uterine surgery. One-fourth of a 200-micrograms tablet of misoprostol (50 micrograms) was placed in the posterior vaginal fornix ev...

16 Jan 97 Biaxin (tablet) Clarithromycin Abbott Laboratories Pharmaceutical Products Division New: use in combination with ranitidine bismuth citrate for treatment of patients with an active duodenal ulcer associated with Helicobacter pylori infection 30 Jan 97 Zithromax (injectable) Azithromycin Pfizer Inc. Treatment of community-acquired pneumonia and pelvic inflammatory disease in patients w...

Microbicides are topically applied, user controlled dosage forms that are being developed to prevent the transmission of HIV during coitus. Early candidates focused on coitally dependent dosage forms such as gels and creams. More recent development has focused on broadening the coitally dependent options through the introduction of films and fast dissolving tablets. Additionally, it has become ...

background: difficulty in cervical dilatation is a hard situation during the procedure of diagnostic dilatation and curettage in some cases. this study was performed to evaluate the effect of vaginal misoprostol for cervical priming before diagnostic dilatation and curettage. methods: in this study 56 women were selected as the candidates for dilatation and curettage. the study was double blind...

Objective: To compare the efficacy and safety of oral misoprostol with prostaglandin E2 vaginal tablets for ripening of cervix and induction of labour at term. Study Design: A non blinded, randomised, controlled trial. Place and Duration of Study: Department of Obstetrics and Gynaecology, Pakistan Air Force Hospital, Air Headquarters Islamabad from July 2005 to January 2006. Patients and Method...

Vaginal dosage forms are seen as a viable option for empowering women to protect themselves from the risk of HIV transmission. Because of limited research in the field, there is a lack of suitable dissolution methods established for determination of drug release from vaginal formulations inside the vaginal tract. The main aim of this study was to develop a simple, reliable and reproducible in v...

AIMS To analyze the outcome of trial of scar in patients with previous caesarean section and to assess the fetal and maternal complications after trial of scar. PATIENTS AND METHODS The study was conducted at Military Hospital, Rawalpindi, Pakistan, with 375 pregnant patients who had a previous delivery by caesarean and who had regular antenatal checkup. Data were recorded on special pro-form...